Arbor Capital Management (Minnesota)’s Pacira BioSciences PCRX Stock Holding History

Arbor Capital Management (Minnesota)’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-61,860	Closed	-$5.5M	–	179
2015 Q1	$5.5M	Sell	61,860 -49,435	-44%	-$5.02M	0.66%	92
2014 Q4	$9.87M	Sell	111,295 -14,600	-12%	-$1.38M	1.26%	14
2014 Q3	$12.2M	Sell	125,895 -40,505	-24%	-$3.94M	1.51%	4
2014 Q2	$15.3M	Sell	166,400 -20,900	-11%	-$1.59M	1.71%	6
2014 Q1	$13.1M	Sell	187,300 -31,306	-14%	-$2.13M	1.38%	15
2013 Q4	$12.6M	Buy	218,606 +6,876	+3%	+$362K	1.04%	40
2013 Q3	$10.1M	Buy	+211,730	New	+$7.72M	0.86%	54

Other funds holding PCRX

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MCM

Marsico Capital Management Denver, Colorado $3.83B AUM 63.68% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arbor Capital Management (Minnesota)'s PCRX Position: Q2 2015 in Review

Arbor Capital Management (Minnesota) sold out of Pacira BioSciences (PCRX) in Q2 2015, closing a stake of 61,860 shares — an estimated $5.5M sold.

Arbor Capital Management (Minnesota) first reported a position in PCRX in Q3 2013 and held it in 7 quarters. The position peaked at $15.3M in Q2 2014. 187 funds tracked by Wall St. Rank hold PCRX as of Q2 2015.

Arbor Capital Management (Minnesota) reported no remaining Pacira BioSciences position as of Q2 2015 after selling out during the quarter.
Arbor Capital Management (Minnesota) sold 61,860 Pacira BioSciences shares in Q2 2015, an estimated $5.5M.
Arbor Capital Management (Minnesota) first reported a position in Pacira BioSciences in Q3 2013 and held it in 7 quarters.
Arbor Capital Management (Minnesota)'s Pacira BioSciences position peaked at $15.3M in Q2 2014.
187 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2015.

Based on Arbor Capital Management (Minnesota)'s 13F filing for Q2 2015, filed 17 Aug 2015.